Delpor, Inc.

About

Delpor, Inc. is a clinical-stage biopharmaceutical company based in Brisbane, California. The company focuses on developing innovative once-yearly therapies for chronic diseases using its proprietary PROZOR technology platform. This platform allows for the sustained release of medications through a small, non-mechanical subcutaneous implant device, which can be inserted in a simple 10-minute procedure. Delpor's product pipeline includes investigational therapies targeting central nervous system disorders such as schizophrenia, opioid use disorder, spasticity, Parkinson's disease, Alzheimer's disease, and multiple sclerosis. The company is actively conducting human trials for its lead candidates, aiming to improve patient adherence and treatment outcomes through its advanced drug delivery system. With a small team of fewer than 25 employees, Delpor is committed to advancing its innovative therapies in the biopharmaceutical field.